共 50 条
- [21] Effects of binder therapies on mineral status in hemodialysis (HD) patients. FASEB JOURNAL, 1997, 11 (03): : 2361 - 2361
- [22] Hemochromatosis (HFE) gene mutations in chronic hemodialysis (HD) patients. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 852A - 852A
- [23] Safety of intravenous injection of iron saccharate in hemodialysis (HD) patients. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A1257 - A1257
- [24] Predictive value for mortality of various mediators in hemodialysis (HD) patients. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 218A - 218A
- [25] The Management of Hypertension in Hemodialysis Patients KIDNEY & BLOOD PRESSURE RESEARCH, 2009, 32 (05): : 311 - 311
- [26] Management of hypertension in hemodialysis patients Current Hypertension Reports, 2009, 11 : 292 - 298
- [30] Knowledge practices and patterns of antihypertensive drug therapy in hemodialysis (HD) patients. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 609A - 609A